financetom
Business
financetom
/
Business
/
Continental's Aumovio aims for higher sales in long term after IPO
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Continental's Aumovio aims for higher sales in long term after IPO
Jun 24, 2025 5:37 AM

BERLIN (Reuters) -Continental's automotive division, set to go public in September under the name Aumovio, hopes to boost sales by 22% in the long term as it sharpens its focus on technologies that add value to the carved-out company, it said on Tuesday.

Continental said Aumovio is targeting a long-term increase in sales to over 24 billion euros ($28 billion) compared with 19.6 billion euros last year, and an adjusted EBIT margin in the range of 6-8%.

"We have a clear strategy for increasing value and are well equipped to take on the market challenges that lie ahead," Aumovio CEO Philipp von Hirschheydt said, giving a strategy update at the group's capital markets day.

On the auto business's exposure to U.S. President Donald Trump's tariffs, which have panicked German carmakers and their suppliers, von Hirschheydt told reporters 92% of its products are produced in the United States or Mexico, meaning they are exempt.

"For many years, we have tried to produce very closely to where our buyers and customers are located," he added.

($1 = 0.8621 euros)

(Reporting by Rachel More, editing by Thomas Seythal)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Anchor Health Properties Acquires Chestnut Funds to Expand Investment Capabilities
Anchor Health Properties Acquires Chestnut Funds to Expand Investment Capabilities
Mar 10, 2026
Transaction launches Anchor Health Capital CHARLOTTESVILLE, Va., Jan. 5, 2026 /PRNewswire/ -- Anchor Health Properties (Anchor), a national, full-service healthcare real estate development, management, and investment company focused exclusively on medical outpatient buildings and specialty healthcare facilities, announced today that it has acquired a majority interest in Chestnut Funds, a long-time investment partner. The transaction represents a strategic alignment rooted...
Pelthos Therapeutics Acquires Xeglyze® (abametapir) Topical Treatment for Head Lice
Pelthos Therapeutics Acquires Xeglyze® (abametapir) Topical Treatment for Head Lice
Mar 10, 2026
Acquisition adds complementary asset to the Pelthos commercial portfolioXeglyze is a novel, FDA-approved prescription medication indicated for the topical treatment of head lice infestation in patients 6 months of age and older DURHAM, N.C., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Pelthos Therapeutics Inc. ( PTHS ) , a biopharmaceutical company committed to commercializing innovative therapeutic products for unmet patient needs (“Pelthos”),...
Form 8.3
Form 8.3
Mar 10, 2026
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of...
Topgolf Callaway Brands Completes Sale of Majority Stake of Topgolf to Leonard Green & Partners
Topgolf Callaway Brands Completes Sale of Majority Stake of Topgolf to Leonard Green & Partners
Mar 10, 2026
Announces Repayment of $1 Billion of Debt and New $200 Million Stock Repurchase Program Company to change corporate name back to Callaway Golf Company and change ticker symbol to CALYCARLSBAD, Calif., Jan. 5, 2026 /PRNewswire/ -- Topgolf Callaway Brands Corp. ( MODG ) is pleased to announce the successful completion of its sale of a 60% stake in its Topgolf and Toptracer...
Copyright 2023-2026 - www.financetom.com All Rights Reserved